Cargando…
Malignant transformation of glucagonoma with SPECT/CT In-111 OctreoScan features: A case report
RATIONALE: Glucagonoma is an uncommon disease but it has been associated with a pattern of symptoms defined as glucagonoma syndrome. These symptoms, if promptly recognized, could help to speed up the diagnosing process. PATIENT CONCERNS: We report a case of a 68-year-old woman with a pancreatic gluc...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815774/ https://www.ncbi.nlm.nih.gov/pubmed/29390362 http://dx.doi.org/10.1097/MD.0000000000009252 |
_version_ | 1783300566735126528 |
---|---|
author | Corrias, Giuseppe Horvat, Natally Monti, Serena Basturk, Olca Lin, Oscar Saba, Luca Bodei, Lisa Reidy, Diane L. Mannelli, Lorenzo |
author_facet | Corrias, Giuseppe Horvat, Natally Monti, Serena Basturk, Olca Lin, Oscar Saba, Luca Bodei, Lisa Reidy, Diane L. Mannelli, Lorenzo |
author_sort | Corrias, Giuseppe |
collection | PubMed |
description | RATIONALE: Glucagonoma is an uncommon disease but it has been associated with a pattern of symptoms defined as glucagonoma syndrome. These symptoms, if promptly recognized, could help to speed up the diagnosing process. PATIENT CONCERNS: We report a case of a 68-year-old woman with a pancreatic glucagonoma. Her symptoms at the onset were typical of the glucagonoma syndrome. DIAGNOSES: After a significant weight loss, she underwent a computer tomography scan of the abdomen, which showed a hypervascular lesion of the tail of the pancreas and hypervascular lesions of the liver. An ultrasound guided biopsy was performed and pathology was consistent with glucagonoma. Her blood glucagon levels were elevated. OUTCOMES: She was treated with chemotherapy and somatostatin analogs. After 4 years, the disease had a malignant transformation, and metastases suddenly started to grow up. She stopped being responsive to treatment and eventually passed away. LESSONS: Due to its rarity, clinical diagnosis is challenging and generally it comes after a long interval since the onset of symptoms. Awareness of physicians and dermatologists of the characteristic necrolytic migratory erythema, and of the other symptoms, often leads to early diagnosis. |
format | Online Article Text |
id | pubmed-5815774 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-58157742018-02-28 Malignant transformation of glucagonoma with SPECT/CT In-111 OctreoScan features: A case report Corrias, Giuseppe Horvat, Natally Monti, Serena Basturk, Olca Lin, Oscar Saba, Luca Bodei, Lisa Reidy, Diane L. Mannelli, Lorenzo Medicine (Baltimore) 6800 RATIONALE: Glucagonoma is an uncommon disease but it has been associated with a pattern of symptoms defined as glucagonoma syndrome. These symptoms, if promptly recognized, could help to speed up the diagnosing process. PATIENT CONCERNS: We report a case of a 68-year-old woman with a pancreatic glucagonoma. Her symptoms at the onset were typical of the glucagonoma syndrome. DIAGNOSES: After a significant weight loss, she underwent a computer tomography scan of the abdomen, which showed a hypervascular lesion of the tail of the pancreas and hypervascular lesions of the liver. An ultrasound guided biopsy was performed and pathology was consistent with glucagonoma. Her blood glucagon levels were elevated. OUTCOMES: She was treated with chemotherapy and somatostatin analogs. After 4 years, the disease had a malignant transformation, and metastases suddenly started to grow up. She stopped being responsive to treatment and eventually passed away. LESSONS: Due to its rarity, clinical diagnosis is challenging and generally it comes after a long interval since the onset of symptoms. Awareness of physicians and dermatologists of the characteristic necrolytic migratory erythema, and of the other symptoms, often leads to early diagnosis. Wolters Kluwer Health 2017-12-15 /pmc/articles/PMC5815774/ /pubmed/29390362 http://dx.doi.org/10.1097/MD.0000000000009252 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0 |
spellingShingle | 6800 Corrias, Giuseppe Horvat, Natally Monti, Serena Basturk, Olca Lin, Oscar Saba, Luca Bodei, Lisa Reidy, Diane L. Mannelli, Lorenzo Malignant transformation of glucagonoma with SPECT/CT In-111 OctreoScan features: A case report |
title | Malignant transformation of glucagonoma with SPECT/CT In-111 OctreoScan features: A case report |
title_full | Malignant transformation of glucagonoma with SPECT/CT In-111 OctreoScan features: A case report |
title_fullStr | Malignant transformation of glucagonoma with SPECT/CT In-111 OctreoScan features: A case report |
title_full_unstemmed | Malignant transformation of glucagonoma with SPECT/CT In-111 OctreoScan features: A case report |
title_short | Malignant transformation of glucagonoma with SPECT/CT In-111 OctreoScan features: A case report |
title_sort | malignant transformation of glucagonoma with spect/ct in-111 octreoscan features: a case report |
topic | 6800 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815774/ https://www.ncbi.nlm.nih.gov/pubmed/29390362 http://dx.doi.org/10.1097/MD.0000000000009252 |
work_keys_str_mv | AT corriasgiuseppe malignanttransformationofglucagonomawithspectctin111octreoscanfeaturesacasereport AT horvatnatally malignanttransformationofglucagonomawithspectctin111octreoscanfeaturesacasereport AT montiserena malignanttransformationofglucagonomawithspectctin111octreoscanfeaturesacasereport AT basturkolca malignanttransformationofglucagonomawithspectctin111octreoscanfeaturesacasereport AT linoscar malignanttransformationofglucagonomawithspectctin111octreoscanfeaturesacasereport AT sabaluca malignanttransformationofglucagonomawithspectctin111octreoscanfeaturesacasereport AT bodeilisa malignanttransformationofglucagonomawithspectctin111octreoscanfeaturesacasereport AT reidydianel malignanttransformationofglucagonomawithspectctin111octreoscanfeaturesacasereport AT mannellilorenzo malignanttransformationofglucagonomawithspectctin111octreoscanfeaturesacasereport |